glp-1 market size 2024 Targeted Peptide Weight Loss Drugs to Reach USD 193.44 Billion by 2034 GLP-1 Nutritional Support Market Size

Double Incretin Receptor Knockout (DIRKO) Mice Reveal an Essential Role for the Enteroinsular Axis in Transducing the Glucoregulatory Actions of DPP-IV Inhibitors

Varnum AA et al

doi: 10.1001/jama.2024.6586

Appetite Regulation Semaglutide GLP-1 acts on receptors in the brain to inhibit sensations of hunger and delay stomach emptying, which in turn increases satiety and decreases food intake

As one research team noted, Early intervention is crucial because patients who dont see initial results are more likely to become discouraged and discontinue treatment altogether

How treatment is chosen: the modern algorithm Current NICE NG28 (and the ADA Standards of Care) personalise the second drug to the person, not just the HbA1c: Established cardiovascular disease, heart failure, or chronic kidney disease SGLT2 inhibitor first add-on (or first-line alongside metformin)